Skip to main content
. 2005 Aug 17;113(12):1808–1813. doi: 10.1289/ehp.8282

Table 4.

ORs (95% CIs) for term low birth weight and intrauterine growth retardation by gestation week (GW) according to level of DBP exposure.

DBP (μg/L) GW 25–28 GW 29–32 GW 33–36 GW 37–40 GW 41–44
Intrauterine growth retardationa
 HAA5 (n) 14,350 14,953 15,414 14,929 2,634
   < 14
   14–19 1.02 (0.89–1.17) 1.00 (0.86–1.13) 0.93 (0.81–1.06) 0.99 (0.86–1.13) 1.22 (0.86–1.72)
   ≥19 1.12 (0.98–1.29) 1.11 (0.98–1.27) 1.00 (0.88–1.14) 0.98 (0.85–1.13) 0.91 (0.63–1.33)
   Continuous 1.01 (1.00–1.01) 1.01 (1.00–1.01) 1.00 (0.99–1.01) 1.00 (0.99–1.01) 1.00 (0.98–1.01)
 DBAA (n)b 9,576 10,302 10,945 10,875 1,913
   < 3
   3.5–5 1.00 (0.84–1.18) 0.97 (0.82–1.14) 1.14 (0.97–1.34) 0.95 (0.81–1.12) 1.23 (0.82–1.85)
   ≥5 1.15 (0.98–1.35) 1.06 (0.91–1.24) 1.08 (0.93–1.27) 0.90 (0.77–1.06) 0.91 (0.60–1.40)
   Continuous 1.06 (1.01–1.12) 1.03 (0.99–1.08) 1.01 (0.96–1.06) 0.99 (0.94–1.04) 0.97 (0.85–1.10)
 DCAA
   < 6
   6–8 1.00 (0.85–1.18) 1.06 (0.90–1.25) 0.92 (0.78–1.08) 1.00 (0.85–1.18) 1.51 (0.98–2.32)
   ≥8 1.04 (0.85–1.29) 1.11 (0.90–1.35) 1.03 (0.84–1.26) 1.27 (1.02–1.59) 1.41 (0.85–2.33)
   Continuous 1.02 (0.99–1.04) 1.03 (1.01–1.05) 1.03 (1.01–1.05) 1.03 (1.01–1.05) 1.03 (0.98–1.08)
 TCAA
   < 4
   4–6 0.96 (0.81–1.14) 1.05 (0.89–1.24) 0.91 (0.78–1.07) 1.12 (0.95–1.32) 1.58 (1.02–2.46)
   ≥6 1.01 (0.86–1.19) 1.15 (0.98–1.34) 1.07 (0.92–1.24) 1.15 (0.98–1.35) 1.48 (0.96–2.31)
   Continuous 1.01 (1.00–1.03) 1.02 (1.01–1.04) 1.03 (1.01–1.05) 1.02 (1.01–1.04) 1.02 (0.98–1.06)
Term low birth weightc
 HAA5 (n) 13,981 14,593 15,195 15,780 2,755
   < 14
   14–19 0.91 (0.69–1.18) 1.04 (0.79–1.36) 1.04 (0.80–1.36) 1.12 (0.87–1.44) 0.74 (0.28–1.98)
   ≥19 1.05 (0.81–1.36) 1.30 (1.00–1.69) 1.20 (0.93–1.55) 1.08 (0.83–1.40) 1.03 (0.39–2.72)
   Continuous 1.01 (0.99–1.02) 1.01 (1.00–1.02) 1.00 (1.01–1.02) 1.00 (0.99–1.02) 0.99 (0.95–1.04)
 DBAA (n)b 9,312 10,043 10,778 11,484 2,003
   < 3
   3.5–5 0.97 (0.69–1.35) 1.05 (0.77–1.45) 1.29 (0.94–1.79) 1.38 (1.02–1.86) 0.99 (0.34–2.85)
   ≥5 1.16 (0.86–1.58) 1.18 (0.87–1.61) 1.49 (1.10–2.02) 1.22 (0.90–1.66) 0.38 (0.10–1.43)
   Continuous 1.03 (0.94–1.12) 1.07 (0.98–1.17) 1.11 (1.01–1.21) 1.10 (1.01–1.20) 0.88 (0.62–1.23)
 DCAA
   < 6
   6–8 0.80 (0.58–1.09) 0.84 (0.61–1.15) 0.94 (0.69–1.27) 0.98 (0.74–1.32) 0.45 (0.13–1.60)
   ≥8 0.87 (0.64–1.18) 0.99 (0.74–1.32) 0.98 (0.73–1.30) 0.91 (0.68–1.21) 0.93 (0.33–2.57)
   Continuous 1.01 (0.97–1.05) 1.02 (0.98–1.06) 1.00 (0.96–1.04) 1.01 (0.97–1.05) 0.94 (0.81–1.09)
 TCAA
   < 4
   4–6 0.79 (0.57–1.09) 0.91 (0.67–1.24) 1.05 (0.77–1.42) 1.15 (0.86–1.53) 0.40 (0.11–1.30)
   ≥6 0.89 (0.66–1.20) 0.98 (0.73–1.33) 1.05 (0.78–1.41) 0.93 (0.69–1.25) 0.64 (0.23–1.79)
   Continuous 1.01 (0.98–1.05) 1.01 (0.98–1.04) 1.00 (0.96–1.03) 1.00 (0.96–1.03) 0.93 (0.80–1.09)
a

Adjusted for parity, education, smoking, and Kessner index.

b

Sample sizes used in analysis of DBAA, DCAA, and TCAA were equal for each gestation age interval.

c

Adjusted for maternal age, parity, education, race, ethnicity, smoking, and Kessner index.